TNON
Tenon Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.72
−1.33%3
Insider buys (3m)
5
Insider sells (3m)
$49.2K
Net value (3m)
-82.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | HRT FINANCIAL LP · 10 percent owner | Purchase | 1,790 | $4.57 |
| Sep 3, 2026 | HRT FINANCIAL LP · 10 percent owner | Sale | 450 | $4.53 |
| Sep 1, 2026 | HRT FINANCIAL LP · 10 percent owner | Purchase | 5,981 | $6.35 |
| Sep 1, 2026 | HRT FINANCIAL LP · 10 percent owner | Sale | 4,932 | $7.07 |
| Sep 1, 2026 | HRT FINANCIAL LP · 10 percent owner | Sale | 1,276 | $4.66 |
| Sep 1, 2026 | HRT FINANCIAL LP · 10 percent owner | Purchase | 12,376 | $5.21 |
| Sep 1, 2026 | HRT FINANCIAL LP · 10 percent owner | Sale | 2,091 | $7.90 |
| Aug 31, 2026 | HRT FINANCIAL LP · 10 percent owner | Sale | 419 | $4.96 |
| Aug 4, 2026 | FOSTER STEVEN M · director, officer: CEO and President | F-InKind | 41,788 | $0.20 |
| Aug 4, 2026 | HOWARD IVAN · director | M-Exempt | 10,732 | $0.00 |
| Aug 4, 2026 | Jacques Kristine M · director | M-Exempt | 10,147 | $0.00 |
| Aug 4, 2026 | WEIGLE ROBERT K · director | M-Exempt | 10,732 | $0.00 |
| Aug 4, 2026 | GINN RICHARD · director, officer: Chief Technology Officer | F-InKind | 44,809 | $0.20 |
| Aug 4, 2026 | FOSTER STEVEN M · director, officer: CEO and President | M-Exempt | 140,936 | $0.00 |
| Aug 4, 2026 | Hochschuler Stephen · director | M-Exempt | 10,732 | $0.00 |
| Aug 4, 2026 | Ferrari Richard · director | M-Exempt | 64,479 | $0.00 |
| Aug 4, 2026 | Williamson Kevin · officer: Chief Financial Officer | M-Exempt | 58,987 | $0.00 |
| Aug 4, 2026 | Williamson Kevin · officer: Chief Financial Officer | F-InKind | 12,978 | $0.20 |
| Aug 4, 2026 | GINN RICHARD · director, officer: Chief Technology Officer | M-Exempt | 126,577 | $0.00 |
| May 5, 2026 | Grawey Nathaniel A. · officer: Chief Commercial Officer | A-Award | 68,201 | $0.00 |
| May 5, 2026 | Geist Wyatt D. · officer: Chief Innovation Officer | A-Award | 136,401 | $0.00 |
| Mar 5, 2026 | Williamson Kevin · officer: Chief Financial Officer | M-Exempt | 1,041 | $0.00 |
| Jan 5, 2026 | Williamson Kevin · director, officer: Chief Financial Officer | F-InKind | 18,518 | $0.93 |
| Jan 5, 2026 | HOWARD IVAN · director | F-InKind | 3,327 | $0.93 |
| Jan 5, 2026 | FOSTER STEVEN M · director, officer: CEO and President | M-Exempt | 140,936 | $0.00 |
| Jan 5, 2026 | Hochschuler Stephen · director | M-Exempt | 10,732 | $0.00 |
| Jan 5, 2026 | Hochschuler Stephen · director | F-InKind | 3,327 | $0.93 |
| Jan 5, 2026 | WEIGLE ROBERT K · director | M-Exempt | 10,732 | $0.00 |
| Jan 5, 2026 | WEIGLE ROBERT K · director | F-InKind | 3,413 | $0.93 |
| Jan 5, 2026 | GINN RICHARD · director, officer: Chief Technology Officer | M-Exempt | 126,577 | $0.00 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026